1. CONSOLIDATED GUIDELINES ONTHE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION SUMMARY OF KEY FEATURES AND RECOMMENDATIONSJUNE 2013 2. Overview •…

1. TIVICAY® (TIV-eh-kay) (Dolutegravir) 2. Date of Approval: August 12, 2013 Approved by :U.S. Food and Drug Administration (FDA) Company: ViiV Healthcare Generic Name :…

Slide 1Pharmacological Interactions with Antiretroviral Drugs Gilles PEYTAVIN PharmD, PhD GHU X Bichat-Cl Bernard - APHP Paris - France Slide 2 Aims & Objectives To understand…

Slide 1BY: Farukh Kohistani and Iva Hoxha 1 Slide 2 Human Immunodeficiency Virus (HIV) A virus that damages or destroys the bodys immune system T cells (CD4 lymphocyte).…

1. Pharmacotherapy of Pediatric HIVInfectionNatella Rakhmanina, MD, PhD, AAHIVSa,b,*,B. Ryan Phelps, MD, MPH, AAHIVSa,cINTRODUCTIONHuman immunodeficiency virus (HIV) infection…

1. Therapeutic Drug Monitoring ofAnti-Retroviral DrugsTrack 3-1 Lecture at International Conference and Exhibition onAnalytical and Bioanalytical Techniques, Hyderabad, IndiaNovember…

1. Discovery and optimization of novel small molecule HIV-1 entry inhibitors using field-based virtual screening and bioisosteric replacement Simon Cocklin, Ph.D. 2. HIV-1…

1. Joseph J. Eron, Jr., MD University of North Carolina Chapel Hill, North Carolina Daniel R. Kuritzkes, MD Brigham and Women’s Hospital Harvard Medical School Boston,…

Slide 1 HIV-1 Antiretroviral Drug Resistance and Resistance Testing HIV and ARV resistance October 2009 Dr Michelle GordonOctober 2009 Slide 2 Evolution of Viral Mutations…

Slide 11 HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams Doctor of Pharmacy Candidate 2011 Wingate University School of Pharmacy Saturday, February…